Eve Duchemin-Pelletier

1.2k total citations · 1 hit paper
10 papers, 885 citations indexed

About

Eve Duchemin-Pelletier is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Eve Duchemin-Pelletier has authored 10 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Biomedical Engineering. Recurrent topics in Eve Duchemin-Pelletier's work include 3D Printing in Biomedical Research (4 papers), Cancer Cells and Metastasis (3 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Eve Duchemin-Pelletier is often cited by papers focused on 3D Printing in Biomedical Research (4 papers), Cancer Cells and Metastasis (3 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Eve Duchemin-Pelletier collaborates with scholars based in France, United States and Switzerland. Eve Duchemin-Pelletier's co-authors include Odile Filhol, Manuel Théry, Martial Balland, Qingzong Tseng, Alexandre Deshière, Hervé Guillou, Ammar Azioune, Irène Wang, Jie Gao and Nicolas Carpi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.

In The Last Decade

Eve Duchemin-Pelletier

10 papers receiving 875 citations

Hit Papers

Spatial organization of the extracellular matrix regulate... 2012 2026 2016 2021 2012 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eve Duchemin-Pelletier France 8 418 333 293 119 77 10 885
Takeomi Mizutani Japan 17 464 1.1× 344 1.0× 264 0.9× 123 1.0× 64 0.8× 47 950
Guido Caluori Czechia 13 405 1.0× 311 0.9× 223 0.8× 74 0.6× 49 0.6× 36 963
Erdem D. Tabdanov United States 11 419 1.0× 202 0.6× 247 0.8× 171 1.4× 73 0.9× 21 783
Jim H. Veldhuis Canada 15 746 1.8× 238 0.7× 435 1.5× 91 0.8× 67 0.9× 25 968
Julia Sero United Kingdom 13 246 0.6× 521 1.6× 276 0.9× 78 0.7× 38 0.5× 20 985
Brian Burkel United States 13 488 1.2× 403 1.2× 150 0.5× 115 1.0× 30 0.4× 26 956
Erik S. Welf United States 21 575 1.4× 468 1.4× 389 1.3× 108 0.9× 137 1.8× 34 1.4k
E. Tim O’Brien United States 8 553 1.3× 323 1.0× 376 1.3× 189 1.6× 90 1.2× 9 1.0k
Hongjun Liu China 15 327 0.8× 474 1.4× 199 0.7× 88 0.7× 79 1.0× 36 1.1k
Navid Bonakdar Germany 12 612 1.5× 325 1.0× 364 1.2× 75 0.6× 128 1.7× 14 931

Countries citing papers authored by Eve Duchemin-Pelletier

Since Specialization
Citations

This map shows the geographic impact of Eve Duchemin-Pelletier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eve Duchemin-Pelletier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eve Duchemin-Pelletier more than expected).

Fields of papers citing papers by Eve Duchemin-Pelletier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eve Duchemin-Pelletier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eve Duchemin-Pelletier. The network helps show where Eve Duchemin-Pelletier may publish in the future.

Co-authorship network of co-authors of Eve Duchemin-Pelletier

This figure shows the co-authorship network connecting the top 25 collaborators of Eve Duchemin-Pelletier. A scholar is included among the top collaborators of Eve Duchemin-Pelletier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eve Duchemin-Pelletier. Eve Duchemin-Pelletier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Duchemin-Pelletier, Eve, et al.. (2018). MyoScreen, a High-Throughput Phenotypic Screening Platform Enabling Muscle Drug Discovery. SLAS DISCOVERY. 23(8). 790–806. 25 indexed citations
2.
Duchemin-Pelletier, Eve, Mithila Burute, Baharia Mograbi, et al.. (2017). Stem Cell-Like Properties of CK2β-down Regulated Mammary Cells. Cancers. 9(9). 114–114. 3 indexed citations
3.
Duchemin-Pelletier, Eve, et al.. (2016). LB815 Validation of EpiScreenTM as a predictive in vitro cell-based assay for screening dermatological drugs by high content approaches. Journal of Investigative Dermatology. 136(8). B11–B11. 1 indexed citations
4.
Duchemin-Pelletier, Eve, et al.. (2015). Fully Automated One-Step Production of Functional 3D Tumor Spheroids for High-Content Screening. SLAS TECHNOLOGY. 21(2). 268–280. 33 indexed citations
5.
Deshière, Alexandre, Eve Duchemin-Pelletier, Delphine Ciais, et al.. (2012). Unbalanced expression of CK2 kinase subunits is sufficient to drive epithelial-to-mesenchymal transition by Snail1 induction. Oncogene. 32(11). 1373–1383. 65 indexed citations
6.
Tseng, Qingzong, Eve Duchemin-Pelletier, Alexandre Deshière, et al.. (2012). Spatial organization of the extracellular matrix regulates cell–cell junction positioning. Proceedings of the National Academy of Sciences. 109(5). 1506–1511. 432 indexed citations breakdown →
7.
Deshière, Alexandre, Eve Duchemin-Pelletier, Delphine Ciais, et al.. (2011). Regulation of epithelial to mesenchymal transition: CK2β on stage. Molecular and Cellular Biochemistry. 356(1-2). 11–20. 13 indexed citations
8.
Tseng, Qingzong, Irène Wang, Eve Duchemin-Pelletier, et al.. (2011). A new micropatterning method of soft substrates reveals that different tumorigenic signals can promote or reduce cell contraction levels. Lab on a Chip. 11(13). 2231–2231. 196 indexed citations
9.
Prudent, Renaud, Caroline Barette, Frédéric Schmidt, et al.. (2010). Antitumor Activity of Pyridocarbazole and Benzopyridoindole Derivatives that Inhibit Protein Kinase CK2. Cancer Research. 70(23). 9865–9874. 63 indexed citations
10.
Giusiano, Sophie, Claude Cochet, Odile Filhol, et al.. (2010). Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: Quantitative immunohistochemistry in tissue microarrays. European Journal of Cancer. 47(5). 792–801. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026